Vida Health
I-Ning (Elaine) Cheng is a seasoned professional with extensive experience in health economics and outcomes research. Currently serving as the Senior Health Economic Lead at Vida Health since January 2020, I-Ning has previously held roles such as Senior Health Data Analyst at Alameda Alliance for Health and Health Economics and Outcome Researcher at Roche. Expertise includes conducting HEOR research with real-world data and generating evidence to support strategic initiatives in the healthcare sector, particularly for HCV and HIV at Gilead Sciences. Earlier career highlights include developing health economic projects at HealthCare Partners and contributing to clinical studies at the University of Southern California, where I-Ning earned a Master's degree in Pharmaceutical Economics and Policy. A Bachelor's degree in Pharmacy was obtained from National Taiwan University.
Vida Health
7 followers
Vida is a virtual care company that combines a human-centric approach with technology to address chronic and co-occurring physical and behavioral health conditions. They provide personalized chronic condition management combined with health coaching and therapy through a mobile and online platform that supports individuals in managing and significantly improving conditions such as diabetes, hypertension, obesity, depression, anxiety, etc. The platform integrates deeply individual expert care with machine learning and remote monitoring to deliver lasting behavior change, health outcomes and cost savings. Vida is in the business of enabling self-insured employers, health plans and providers to take better care of their employees and members. Vida is trusted by Fortune 1000 companies, major national payers, and large providers to activate, engage, and empower their employees to live their healthiest lives. Based in San Francisco, CA, Vida is backed by investors including Khosla Ventures, StartX, Aspect Ventures, Canvas, Workday, and Nokia.